News | Nanologica

Analytica in Munich

14 June, 2022

Next week from June 21 to 24, Nanologica will be at Analytica in Munich! Analytica is the leading industry event for analytics, laboratory technology and biotechnology. With 1,200 exhibitors, 36,000 visitors and 55,000 square meters of exhibition space, Analytica is the largest trade fair for analysis, laboratory technology and biotechnology in the world. As the industry’s definitive forum, Analytica gives visitors a comprehensive market overview and information about the latest developments in laboratory technology, analysis

Bulletin from the Annual General Meeting of Nanologica AB (publ)

2 June, 2022

Today June 2nd, 2022, Nanologica AB (publ) held its annual general meeting for the financial year 2021, where the following resolutions were passed. Adoption of income statement and balance sheet for the financial year 2021 and disposition of result The annual general meeting adopted the income statement and balance sheet for the company and for the group in accordance with the presented accounting documents, and resolved, in accordance with the board’s proposal, that the accumulated

Kommuniké från årsstämma i Nanologica AB (publ)

2 June, 2022

Nanologica AB (publ) höll idag den 2 juni 2022 sin årsstämma för verksamhetsåret 2021, varvid följande beslut fattades. Fastställande av resultat- och balansräkning, disponering av resultat Årsstämman fastställde resultaträkningen och balansräkningen för bolaget och för koncernen enligt framlagda redovisningshandlingar samt beslutade, i enlighet med styrelsens förslag, att ansamlad förlust om -46 224 712 kronor överförs i ny räkning. Beslutet innebär således att ingen utdelning lämnas för räkenskapsåret 2021. Ansvarsfrihet Årsstämman beviljade styrelseledamöterna och verkställande

CEO Andreas Bhagwani presenting At Naventus Healthcare Summit May 10, 2022

11 May, 2022

Introducing NLAB Saga®- a new generation silica for preparative chromatography

9 May, 2022

We are officially launching NLAB Saga® – Nanologica’s silica for preparative chromatography! NLAB Saga was developed with a clear goal in mind – to increase the availability of better and cheaper peptide and oligonucleotide-based medicines to a larger number of patients across the world, for the betterment of mankind. NLAB Saga has been specifically developed to meet the strict requirements of industrial scale purification by chromatography. Due to its exceptional mechanical and chemical stability, NLAB

Kallelse till årsstämma i Nanologica AB (publ)

4 May, 2022

Aktieägarna i Nanologica AB (publ), org.nr 556664-5023 (”Bolaget”) kallas härmed till årsstämma torsdagen den 2 juni 2022, klockan 12.00, i The Parks lokaler på Magnus Ladulåsgatan 1, Stockholm. Rätt att delta vid stämman Aktieägare som önskar delta i årsstämman ska: dels vara registrerad i eget namn (inte förvaltarregistrerad) i den av Euroclear Sweden AB förda aktieboken tisdagen den 24 maj 2022, dels anmäla sitt deltagande så att anmälan är Bolaget tillhanda senast måndagen den 30

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

Latest news

Categories

News archive